Regulatory Affairs Professionals Society
Keynote speaker at RAPS' annual meeting Sept. 13-14 in Washington is FDA Deputy Com. Novitch, who will speak on the development of agency action plans for the next decade and beyond. "Regulatory Perspectives" panel moderated by D.C. attorney James Phelps will include six officials from the agency's Centers for Drugs & Biologics and for Devices & Radiological Health. Workshop on ANDA/Patent Restoration bill will feature Milton Bass (Bass Ullman & Lustigman); PMA counsel Neil Mulcahy; and Natl. Assn. of Pharmaceutical Mfrs. Exec Director George Schwartz
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."